Breaking News

GRAM Expands Footprint with New Finishing Center

New 110,000 sq.-ft. finishing center is the injectable CDMO's fourth GMP manufacturing facility.

By: Kristin Brooks

Managing Editor, Contract Pharma

Grand River Aseptic Manufacturing (GRAM), an injectable contract development and manufacturing organization (CDMO), has opened a new finishing and warehouse center located at 6670 Patterson Ave S.E., in Grand Rapids, MI. The company’s fourth GMP manufacturing facility adds an additional 110,000 sq.-ft. to the company’s growing footprint. The facility houses four inspection rooms; four finishing rooms; a QC laboratory; a weigh and dispense clean room; walk-in coolers/freezers; walk-in incubators; incoming and outgoing warehouse; and multiple truck bays.
 
GRAM also invested in advanced, industry-leading finishing equipment, including a new MG America labeling machine with Dividella packaging line, and two Stevanato fully-automated inspection systems.
 
“Opening another world-class facility in a year since our last is a significant milestone. The GRAM team is extraordinary, and the ribbon cutting followed by a company-wide celebration was entirely dedicated to them,” said GRAM President and CEO Tom Ross. “As we’ve expanded and modernized, the life sciences industry has recognized something we’ve had a front row seat to – that Grand Rapids has top-notch talent driving innovation and growth in Michigan and beyond.”

A ribbon cutting was held honoring GRAM employees as they celebrate the new Patterson Avenue facility.

@font-face {font-family:”Cambria Math”; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:3 0 0 0 1 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:””; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Times New Roman”,serif; mso-fareast-font-family:”Times New Roman”;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:”Calibri”,sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:”Times New Roman”; mso-bidi-theme-font:minor-bidi;}div.WordSection1 {page:WordSection1; The new facility marks the latest milestone in GRAM’s rapid growth to increase capacity and throughput to meet increased demand. The U.S.-based CDMO is currently on its phase II expansion of its large-scale fill/finish facility and has invested in a duplicate Bausch+Ströbel vial filler with SKAN Isolator technology as well as a VarioSys syringe and vial filler which will further increase capacity.

Visit GRAM at CPhI North America Booth #901

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters